ENANTIOS AG

Solution to analyze chiral molecules and biologics.

Modern pharmaceutics are becoming more and more structurally complex, and traditional measurement techniques are slowing down the discovery pipeline. At Enantios we are leveraging new measurement technology to accelerate drug development and discovery and enable more complete quality testing in the manufacturing stage.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

01.07.2024

AG Conversion

Deal

26.06.2024

Fundraising Round

No Jobs

Videos

ENANTIOS

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

ESA BIC Switzerland

Together with partners, ESA BIC Switzerland is the place for entrepreneurs with a link to space technologies in order to realise their innovative ideas and transfer technologies from space to other areas of the economy. So, that doesn't mean rocket science, but applies to multiple application fields such as navigation and positioning, communications techniques, Earth observation, materials, processes, signals or robotics. So let's see how much space is hidden in your innovative business idea! The ESA Business Incubation Centre Switzerland (ESA BIC Switzerland) is a nationwide initiative that will officially open in Q4 2016 and is managed by ETH Zurich, in collaboration with IFJ, Impact Hub Zurich and AP Swiss.

Website

ETH Spin-off

http://www.vpf.ethz.ch/transfer/firmgruend/spinoff_list/by_years/2009

Website

Venture Leaders Biotech

ENANTIOS AG

Solution to analyze chiral molecules and biologics.

Headquarter:
Zürich

Foundation Date:
December 2022

Technology:

  • Biotech

Sectors:

  • Antibodies
  • Biotech
  • Chemicals
  • Drug development platforms
  • Instruments
  • Drug discovery
  • Optics
  • Protein drugs
  • Small molecule drugs

Support received

  • Support venture leaders
  • Support venturekick
  • Support TOP 100